Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
18.85
+0.47 (2.56%)
Jul 3, 2025, 1:00 PM - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $606.22 million as of July 3, 2025. Its market cap has decreased by -18.23% in one year.
Market Cap
606.22M
Enterprise Value
276.07M
1-Year Change
-18.23%
Ranking
Category
Stock Price
$18.85
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $606.22M, an increase of 271.92%. That is a compound annual growth rate of 106.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 606.22M | -6.04% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |